Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

NCT02562742 · clinicaltrials.gov ↗

COMPLETED

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: SOF
DRUG: REB

Sponsor

Gilead Sciences

Collaborators

[object Object]